MIMS CDS footer logo
  • Home
  • Solutions
    • MIMS Integrated
    • eMIMSplus
  • Practices
    • Hospitals
    • Pharmacies
    • Clinics
    • Telemedicine
    • Become A Partner
  • Learn More
    • Editorial Process
    • Testimonials
    • FAQs
    • Contact Support
  • Blog
  • CONTACT US

Decision Support and Prescribing Safety: Real-World Evidence from Healthcare Facilities in Vietnam

by MIMS CDS Asia | Aug 26, 2026 | Articles

8 minutes read time Prescribing Complexity and the Need for Real-Time Decision Support Medication errors remain a persistent challenge in clinical practice, particularly during the prescribing stage of the medication-use process. The World Health Organization has...

Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Bleeding

by MIMS CDS Asia | May 22, 2026 | Articles

5 minutes read time Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed in the management of various conditions, including major depressive disorder, generalised anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder....

St John’s Wort: Clinically Important Drug Interactions

by MIMS CDS Asia | Mar 16, 2026 | Articles

7 minutes read time St John’s Wort (Hypericum perforatum) is a herbal medicinal product commonly used for the management of mild to moderate depressive symptoms. Its widespread availability and use alongside prescribed medicines have raised clinically relevant...

Enzyme-Inducing Antiepileptic Drugs and the Risk of Vitamin D Deficiency

by MIMS CDS Asia | Feb 6, 2026 | Articles

6 minutes read time Epilepsy is a chronic neurological disorder characterised by an enduring predisposition to generate epileptic seizures. It is defined by the International League Against Epilepsy (ILAE) as [1]: at least two unprovoked seizures occurring more than...

Understanding Hypoglycaemia Risks in Diabetes from Polypharmacy Practices

by MIMS CDS Asia | Jan 6, 2026 | Articles

6 minutes read time Hypoglycaemia, a condition in which blood glucose concentration falls below 70 mg/dL (3.9 mmol/L) [1], remains a clinically important concern for patients with Type 2 diabetes (T2DM), particularly when multiple comorbidities necessitate...
« Older Entries

Recent Posts

  • Decision Support and Prescribing Safety: Real-World Evidence from Healthcare Facilities in Vietnam
  • Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Bleeding
  • St John’s Wort: Clinically Important Drug Interactions
  • Enzyme-Inducing Antiepileptic Drugs and the Risk of Vitamin D Deficiency
  • Understanding Hypoglycaemia Risks in Diabetes from Polypharmacy Practices
MIMS CDS footer logo

Safer Medications, Better Care.

  • Follow
  • Follow
Navigate
Solutions
– MIMS Integrated
– eMIMSplus
Hospitals
Pharmacies
Clinics
Blog
Editorial Process
Testimonials
FAQs
Become a Partner
Contact Us
Get In Touch


Sales

cdssales@mims.com



Support

cdssupport@mims.com



Regional Headquarters

438B Alexandra Rd, Alexandra Technopark, #06-11 Singapore 119968
Copyright © 2026 MIMS CDS Asia | Privacy Policy